tiprankstipranks
Trending News
More News >
Gelteq Limited (GELS)
NASDAQ:GELS
US Market
Advertisement

Gelteq Limited (GELS) Price & Analysis

Compare
30 Followers

GELS Stock Chart & Stats


Gelteq Limited News

GELS FAQ

What was Gelteq Limited’s price range in the past 12 months?
Gelteq Limited lowest stock price was $0.77 and its highest was $5.50 in the past 12 months.
    What is Gelteq Limited’s market cap?
    Gelteq Limited’s market cap is $15.29M.
      When is Gelteq Limited’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Gelteq Limited’s earnings last quarter?
      Currently, no data Available
      Is Gelteq Limited overvalued?
      According to Wall Street analysts Gelteq Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Gelteq Limited pay dividends?
        Gelteq Limited does not currently pay dividends.
        What is Gelteq Limited’s EPS estimate?
        Gelteq Limited’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Gelteq Limited have?
        Gelteq Limited has 9,438,075 shares outstanding.
          What happened to Gelteq Limited’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Gelteq Limited?
          Currently, no hedge funds are holding shares in GELS

          Company Description

          Gelteq Limited

          Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.

          Gelteq Limited (GELS) Earnings & Revenues

          Currently, no data available
          Please return soon. This page is being updated.
          Similar Stocks
          Company
          Price & Change
          Follow
          Kala Pharmaceuticals
          cbdMD
          Cosmos Holdings
          Petros Pharmaceuticals
          Shuttle Pharmaceuticals Holdings, Inc.

          Ownership Overview

          0.67%99.33%
          Insiders
          Mutual Funds
          0.67% Other Institutional Investors
          99.33% Public Companies and
          Individual Investors

          Options Prices

          Currently, No data available
          ---
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis